Annual and transition report of foreign private issuers [Sections 13 or 15(d)]

Consolidated statements of changes in shareholders' equity

v3.25.0.1
Consolidated statements of changes in shareholders' equity - USD ($)
$ in Thousands
Total
Ordinary Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   74,845,441      
Beginning balance at Dec. 31, 2021 $ 84,914 $ 205 $ 324,614 $ 160 $ (240,065)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options and vesting of RSUs (in shares)   1,230,823      
Exercise of stock options and vesting of RSUs 2,034 $ 4 2,030    
Issuance of ordinary shares under the employee share purchase plan (in shares)   357,508      
Issuance of ordinary shares under the employee share purchase plan 2,083 $ 1 2,082    
Share-based compensation 16,987   16,987    
Deferred costs in relation to initial public offering 121   121    
Other comprehensive (loss) income (527)     (527)  
Net loss (83,661)       (83,661)
Ending balance (in shares) at Dec. 31, 2022   76,433,772      
Ending balance at Dec. 31, 2022 21,951 $ 210 345,834 (367) (323,726)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options and vesting of RSUs (in shares)   1,923,898      
Exercise of stock options and vesting of RSUs 2,307 $ 5 2,302    
Issuance of ordinary shares under the employee share purchase plan (in shares)   293,208      
Issuance of ordinary shares under the employee share purchase plan 1,259 $ 1 1,258    
Share-based compensation 18,164   18,164    
Other comprehensive (loss) income 1,239     1,239  
Net loss $ (29,373)       (29,373)
Ending balance (in shares) at Dec. 31, 2023 78,650,878 78,650,878      
Ending balance at Dec. 31, 2023 $ 15,547 $ 216 367,558 872 (353,099)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Exercise of stock options and vesting of RSUs (in shares)   3,692,511      
Exercise of stock options and vesting of RSUs 4,697 $ 10 4,687    
Issuance of ordinary shares under the employee share purchase plan (in shares)   275,122      
Issuance of ordinary shares under the employee share purchase plan 1,486 $ 1 1,485    
Share-based compensation 17,719   17,719    
Other comprehensive (loss) income (484)     (484)  
Net loss $ (11,457)       (11,457)
Ending balance (in shares) at Dec. 31, 2024 82,618,511 82,618,511      
Ending balance at Dec. 31, 2024 $ 27,508 $ 227 $ 391,449 $ 388 $ (364,556)